Smith Jason Drew
SEC insider (Form 3/4/5 filer). CIK 0001821479. General Counsel at UroGen Pharma Ltd. (URGN). 22 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in PRINCETON, NJ.
Companies Smith Jason Drew has filed insider reports for
- UroGen Pharma Ltd. (URGN): Officer, General Counsel
Smith Jason Drew
CIK: 0001821479
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
UroGen Pharma Ltd.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Sep 8, 2026URGN
UroGen Pharma Ltd.
SaleDirect1.5K shares at avg. $42.54$65K - Sep 7, 2026URGN
UroGen Pharma Ltd.
ExerciseDirect3.3K shares- - Feb 3, 2026URGN
UroGen Pharma Ltd.
SaleDirect2.7K shares at avg. $19.69$52K - Feb 3, 2026URGN
UroGen Pharma Ltd.
SaleDirect1.6K shares at avg. $19.69$32K - Feb 3, 2026URGN
UroGen Pharma Ltd.
SaleDirect3.2K shares at avg. $19.69$63K - Jan 31, 2026URGN
UroGen Pharma Ltd.
ExerciseDirect3.3K shares- - Jan 31, 2026URGN
UroGen Pharma Ltd.
ExerciseDirect5.5K shares- - Jan 31, 2026URGN
UroGen Pharma Ltd.
ExerciseDirect6.7K shares- - Jan 31, 2026URGN
UroGen Pharma Ltd.
AwardDirectRestricted Stock Units
32.6K shares- - Sep 8, 2025URGN
UroGen Pharma Ltd.
SaleDirect1.5K shares at avg. $19.11$29K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 | URGN UroGen Pharma Ltd. | Sale | 1,519 | $42.54 | $64,618 | Direct |
| Sep 7, 2026 | URGN UroGen Pharma Ltd. | Exercise | 3,334 | - | $0 | Direct |
| Feb 3, 2026 | URGN UroGen Pharma Ltd. | Sale | 2,654 | $19.69 | $52,257 | Direct |
| Feb 3, 2026 | URGN UroGen Pharma Ltd. | Sale | 1,608 | $19.69 | $31,662 | Direct |
| Feb 3, 2026 | URGN UroGen Pharma Ltd. | Sale | 3,217 | $19.69 | $63,343 | Direct |
| Jan 31, 2026 | URGN UroGen Pharma Ltd. | Exercise | 3,333 | - | $0 | Direct |
| Jan 31, 2026 | URGN UroGen Pharma Ltd. | Exercise | 5,500 | - | $0 | Direct |
| Jan 31, 2026 | URGN UroGen Pharma Ltd. | Exercise | 6,667 | - | $0 | Direct |
| Jan 31, 2026 | URGN UroGen Pharma Ltd. | Award Restricted Stock Units | 32,609 | - | - | Direct |
| Sep 8, 2025 | URGN UroGen Pharma Ltd. | Sale | 1,520 | $19.11 | $29,047 | Direct |
1-10 of 22 transactions